Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metagenomic and Metabolomic Analysis Study: Effect of Bifidobacterium Multistrain Probiotic Supplementation on the Abundance and Diversity of Gut Pathogen Microbiota and Levels of Fecal Short Chain Fatty Acid (SCFA) of Preterm Infants in the Neonatal Intensive Care Unit (NICU)

NCT07213414 is registered in ClinicalTrials.gov with Hasanuddin University as lead sponsor.

NCT NCT07213414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07213414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metagenomic and Metabolomic Analysis Study: Effect of Bifidobacterium Multistrain Probiotic Supplementation on the Abundance and Diversity of Gut Pathogen Microbiota and Levels of Fecal Short Chain Fatty Acid (SCFA) of Preterm Infants in the Neonatal Intensive Care Unit (NICU)
Lead sponsor
Hasanuddin University
Phase
Phase 1
Overall status
Active, not recruiting
Start date
September 2, 2024
Completion date
September 30, 2025
Enrollment
72 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

low birth weight neonates, prematurity